Jump Financial, LLC Shattuck Labs, Inc. Transaction History

Jump Financial, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$3.0 - $4.85 $156,600 - $253,169	-52,200 Closed	0 $0
Q2 2024 Aug 14, 2024	BUY	$3.56 - $11.18 $71,563 - $224,740	20,102 Added 62.63%	52,200 $201,000
Q1 2024 May 13, 2024	BUY	$7.37 - $10.09 $236,562 - $323,868	32,098 New	32,098 $286,000
Q2 2022 Aug 09, 2022	SELL	$2.7 - $4.59 $19,170 - $32,589	-7,100 Reduced 29.96%	16,600 $67,000
Q1 2022 May 12, 2022	SELL	$4.22 - $8.89 $38,824 - $81,788	-9,200 Reduced 27.96%	23,700 $101,000
Q4 2021 Feb 10, 2022	BUY	$8.36 - $21.08 $275,044 - $693,532	32,900 New	32,900 $280,000

28.8M

300

1.2K

Ticker STTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,382,000
Market Cap $47M
Description
Shattuck Labs, Inc., a clinical-stage biotechnology company, develops therapeutics for the treatment of cancer and autoimmune disease in the United States. The company's lead product candidate is SL-172154, which is in Phase 1 clinical trial for the treatment of ovarian, fallopian tube, and peritoneal cancers. It also develops SL-279252 that is ...

Get notified when there are updates to the investment portfolio of Jump Financial, LLC, based on Form 13F filings with the SEC.

Stay updated on Jump Financial, LLC with notifications on news.